Attralus, Inc.
Biotechnology company · Burlingame, California, United States
Attralus, Inc. is a biotechnology company headquartered in Burlingame, California, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $56 million sold in a notice filed in 2024.
Attralus at a glance
What does Attralus do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $56 million sold (2024).
Frequently asked questions about Attralus
Where is Attralus headquartered?
Attralus, Inc. is headquartered in Burlingame, California, United States.
What does Attralus do?
Attralus, Inc. is a biotechnology company.
When was Attralus founded?
The earliest incorporation on record for Attralus, Inc. is in 2019, according to public company registers.
Similar companies
- Inflammatix, Inc.Burlingame, California, United States
- Hinge Bio, Inc.Burlingame, California, United States
- Magnus Medical, Inc.Burlingame, California, United States
- Optofluidics, Inc.Burlingame, California, United States
- Afasci, Inc.Burlingame, California, United States
- Nextrast, IncBurlingame, California, United States
- Biodesy LLCBurlingame, California, United States
- Color Health, Inc.Burlingame, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences